Eide Nils A, Noer Agate, Jespersen Henrik, Jebsen Peter, Geisler Jürgen
Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Department of Oncology, Oslo University Hospital, Oslo, Norway.
Case Rep Oncol. 2024 Oct 9;17(1):1131-1139. doi: 10.1159/000541341. eCollection 2024 Jan-Dec.
This report presents a case of an exceptionally delayed distant recurrence of a choroidal melanoma, occurring 4 decades after the enucleation of the affected eye.
In 1977, a 29-year-old man underwent enucleation for a choroidal melanoma. At the age of 68 years, he was diagnosed with advanced prostate cancer. Although the metastatic prostate cancer responded to treatment, a persistent lung lesion warranted further examination. A lung biopsy, somewhat surprisingly, confirmed the presence of melanoma metastasis, 4 decades after the enucleation. The cells were positive for Melan-A, while no mutation was identified. Two years later, new lesions appeared in the liver, and CT showed progression with multiple new sites. A liver biopsy revealed again melanoma recurrence, and its choroidal origin was verified by the presence of a mutation. The patient underwent radiation therapy for the lung and liver lesions, followed by immunotherapy. However, the patient died 11 months after the recurrence in the liver. In this case report, the micrometastatic melanoma cells appear to have remained dormant for an extended period, before the patient's treatment in 1977, but the reason for the late reactivation from the dormant state remains unclear.
The recurrence of a choroidal melanoma is substantiated by the histopathological and molecular analyses, including the finding of a mutation. This case exemplifies a remarkably delayed distant recurrence of a choroidal melanoma, which manifested clinically 40 years following enucleation.
本报告介绍了一例脉络膜黑色素瘤异常延迟的远处复发病例,发生在患眼摘除术后40年。
1977年,一名29岁男性因脉络膜黑色素瘤接受了眼球摘除术。68岁时,他被诊断出患有晚期前列腺癌。尽管转移性前列腺癌对治疗有反应,但肺部的一个持续病变仍需进一步检查。令人惊讶的是,肺活检证实了黑色素瘤转移的存在,这距离眼球摘除已有40年。细胞Melan-A呈阳性,未发现突变。两年后,肝脏出现新病变,CT显示多处新部位有进展。肝活检再次显示黑色素瘤复发,通过一个突变的存在证实了其脉络膜起源。患者接受了肺部和肝脏病变的放射治疗,随后进行了免疫治疗。然而,患者在肝脏复发11个月后死亡。在本病例报告中,微转移黑色素瘤细胞在1977年患者接受治疗之前似乎已经长期处于休眠状态,但休眠状态后期重新激活的原因仍不清楚。
脉络膜黑色素瘤的复发通过组织病理学和分子分析得到证实,包括发现一个突变。本病例体现了脉络膜黑色素瘤显著延迟的远处复发,在眼球摘除术后40年临床出现。